Tran, Ha Vu <br/><br/>
Copy Number Alterations in Tumor Genomes Deleting Antineoplastic Drug Targets Partially Compensated by Complementary Amplifications.  [electronic resource] 

 -  Cancer genomics & proteomics   
 - 365-378 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1790-6245 
<br/><br/><label>Standard No.: </label>10.21873/cgp.20095  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Axitinib<br/>Carcinoma, Renal Cell--drug therapy<br/>DNA Copy Number Variations--genetics<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Genome, Human--drug effects<br/>Glioblastoma--drug therapy<br/>Humans<br/>Imidazoles--therapeutic use<br/>Indazoles--therapeutic use<br/>Indoles--therapeutic use<br/>Male<br/>Molecular Targeted Therapy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Pyrroles--therapeutic use<br/>Sorafenib<br/>Sunitinib<br/>Vascular Endothelial Growth Factor Receptor-1--genetics<br/>Vascular Endothelial Growth Factor Receptor-3--genetics<br/>fms-Like Tyrosine Kinase 3--genetics